View Larger Image Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variantClinical studies could begin as early as August, subject to regulatory approvals, Pfizer says.By David Hilbern|2021-07-09T05:25:35-05:00July 9, 2021|Bankruptcy|0 CommentsShare This Story, Choose Your Platform!FacebookTwitterLinkedInEmail About the Author: David Hilbern Related Posts SpaceX looks to raise $1.7 billion in new funding, boosting its valuation to $127 billion May 22, 2022 Biden says ‘hello’ to North Korea’s Kim amid tensions over weapons tests May 22, 2022 Monkeypox is spreading around the world. What is the disease and how dangerous is it? May 20, 2022